BIORESTORATIVE THERAPIES, INC. Accretion Expense
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Accretion Expense of $2.81 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2022-03-30
- BIORESTORATIVE THERAPIES, INC. accretion expense for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. accretion expense for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. accretion expense for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. accretion expense for the quarter ending 2020-03-31 was $2.81M, a 2100.49% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. accretion expense for fiscal 2020 was $2.81M, a 412.93% increase from fiscal 2019.
- BIORESTORATIVE THERAPIES, INC. accretion expense for fiscal 2019 was $548.03K, a 12.18% decline from fiscal 2018.
- BIORESTORATIVE THERAPIES, INC. accretion expense for fiscal 2018 was $624.04K, a 202.52% increase from fiscal 2017.
- BIORESTORATIVE THERAPIES, INC. accretion expense for fiscal 2017 was $206.28K, a 415.04% increase from fiscal 2016.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 6 month as first filed | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $2.81M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $2.81M 10-Q · filed 2021-11-15 | $2.98M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $2.81M 10-Q · filed 2021-08-16 | $2.98M derived: sum of 3 quarters · filed 2021-08-16 | $3.12M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $2.81M 10-Q · filed 2021-05-17 | $2.98M derived: sum of 2 quarters · filed 2021-05-17 | $3.12M derived: sum of 3 quarters · filed 2021-05-17 | $3.23M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $172.68K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-30 | $312.90K derived: sum of 2 quarters · filed 2021-04-30 | $420.28K derived: sum of 3 quarters · filed 2021-04-30 | $548.03K 10-K · filed 2021-04-30 | |
| 2019-09-30 | $140.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-12 | $247.60K derived: sum of 2 quarters · filed 2021-04-12 | $375.34K 10-Q · filed 2021-04-12 | $571.48K derived: sum of 4 quarters · filed 2021-04-12 | |
| 2019-06-30 | $107.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-12 | $235.12K 10-Q · filed 2021-04-12 | $431.25K derived: sum of 3 quarters · filed 2021-04-12 | $525.74K derived: sum of 4 quarters · filed 2021-04-12 | |
| 2019-03-31 | $127.74K 10-Q · filed 2021-03-29 | $323.88K derived: sum of 2 quarters · filed 2021-03-29 | $418.36K derived: sum of 3 quarters · filed 2021-03-29 | $684.22K derived: sum of 4 quarters · filed 2021-03-29 | |
| 2018-12-31 | $196.13K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $290.62K derived: sum of 2 quarters · filed 2021-03-18 | $556.48K derived: sum of 3 quarters · filed 2021-03-18 | $624.04K 10-K · filed 2021-03-18 | |
| 2018-09-30 | $94.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $360.35K derived: sum of 2 quarters · filed 2019-11-13 | $427.91K 10-Q · filed 2019-11-13 | $500.76K derived: sum of 4 quarters · filed 2019-11-13 | |
| 2018-06-30 | $265.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $333.43K 10-Q · filed 2019-08-14 | $406.28K derived: sum of 3 quarters · filed 2019-08-14 | $450.35K derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $67.56K 10-Q · filed 2019-05-15 | $140.41K derived: sum of 2 quarters · filed 2019-05-15 | $184.48K derived: sum of 3 quarters · filed 2019-05-15 | $232.79K derived: sum of 4 quarters · filed 2019-05-15 | |
| 2017-12-31 | $72.85K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $116.92K derived: sum of 2 quarters · filed 2019-03-29 | $165.23K derived: sum of 3 quarters · filed 2019-03-29 | $206.28K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $44.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $92.38K derived: sum of 2 quarters · filed 2018-11-13 | $133.43K 10-Q · filed 2018-11-13 | $157.78K derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | $48.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $89.36K 10-Q · filed 2018-08-14 | $89.36K 10-Q · filed 2017-08-14 | $113.72K derived: sum of 3 quarters · filed 2018-08-14 | $126.50K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $41.05K 10-Q · filed 2018-05-15 | $65.41K derived: sum of 2 quarters · filed 2018-05-15 | $78.19K derived: sum of 3 quarters · filed 2018-05-15 | $78.19K derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $24.35K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $37.14K derived: sum of 2 quarters · filed 2018-04-02 | $37.14K derived: sum of 3 quarters · filed 2018-04-02 | $40.05K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $12.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $12.78K derived: sum of 2 quarters · filed 2017-11-14 | $15.70K 10-Q · filed 2017-11-14 | $53.16K derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $2.92K 10-Q · filed 2017-08-14 | $40.38K derived: sum of 3 quarters · filed 2017-08-14 | $81.99K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | $2.92K 10-Q · filed 2017-05-15 | $40.38K derived: sum of 2 quarters · filed 2017-05-15 | $81.99K derived: sum of 3 quarters · filed 2017-05-15 | $88.00K derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | $37.46K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $79.07K derived: sum of 2 quarters · filed 2017-03-22 | $85.09K derived: sum of 3 quarters · filed 2017-03-22 | $85.09K 10-K · filed 2017-03-22 | |
| 2015-09-30 | $41.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $47.63K derived: sum of 2 quarters · filed 2016-11-14 | $47.63K 10-Q · filed 2016-11-14 | $72.56K derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-06-30 | $6.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $6.01K 10-Q · filed 2016-08-15 | $30.95K derived: sum of 3 quarters · filed 2016-08-15 | $30.95K derived: sum of 4 quarters · filed 2016-08-15 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-13 | $24.93K derived: sum of 2 quarters · filed 2016-05-13 | $24.93K derived: sum of 3 quarters · filed 2016-05-13 | ||
| 2014-12-31 | $24.93K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $24.93K derived: sum of 2 quarters · filed 2016-03-30 | $24.93K 10-K · filed 2016-03-30 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-23 | $0.00 10-Q · filed 2015-11-23 | |||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-14 | ||||
| 2013-12-31 | $5.07K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |